SwePub
Sök i LIBRIS databas

  Extended search

onr:"22462330"
 

Search: onr:"22462330" > Atrial Fibrillation...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients

Wange, Niklas (author)
Anan, Intissar (author)
Ericzon, Bo-Göran (author)
show more...
Pennlert, Johanna (author)
Pilebro, Björn (author)
Suhr, Ole B. (author)
Wixner, Jonas (author)
show less...
 (publisher)
 (publisher)
LIPPINCOTT WILLIAMS & WILKINS 2018
2018
English.
In: Transplantation. - 0041-1337. ; 102:2, e59-e66
  • swepub:Mat__t
Abstract Subject headings
Close  
  • Background. Central nervous system (CNS) complications are increasingly noted in liver transplanted (LTx) hereditary transthyretin amyloid (ATTRm) amyloidosis patients; this suggests that the increased survival allows for intracranial ATTRm formation from brain synthesized mutant TTR. However, atrial fibrillation (AF), a recognised risk factor for ischemic CNS complications, is also observed after LTx. The aim of the study was to investigate the occurrence of CNS complications and AF in LTx ATTRm amyloidosis patients. Methods. The medical records of all LTx ATTRm amyloidosis patients in the county of Vasterbotten, Sweden, were investigated for information on CNS complications, AF, anticoagulation (AC) therapy, hypertension, cardiac ischemic disease, hypertrophy, and neurological status. Results. Sixty-three patients that had survived for 3 years or longer after LTx were included in the analysis. Twenty-five patients had developed 1 or more CNS complications at a median of 21 years after onset of disease. AF was noted in 21 patients (median time to diagnosis 24 years). Cerebrovascular events (CVE) developed in 17 (median time to event 21 years). CVEs occurred significantly more often in patients with AF (P < 0.002). AC therapy significantly reduced CVEs, including bleeding in patients with AF (P = 0.04). Multivariate analysis identified AF as the only remaining regressor with a significant impact on CVE (hazard ratio, 3.8; 95% confidence interval 1.1-9.5; P = 0.029). Conclusions. AF is an important risk factor for CVE in LTx ATTRm amyloidosis patients, and AC therapy should be considered. However, the increased bleeding risk with AC therapy in patients with intracranial amyloidosis should be acknowledged.

Subject headings

Medical and Health Sciences  (hsv)
Clinical Medicine  (hsv)
Cardiac and Cardiovascular Systems  (hsv)
Medicin och hälsovetenskap  (hsv)
Klinisk medicin  (hsv)
Kardiologi  (hsv)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view